GC Wellbeing said Monday it has confirmed the efficacy of the new drug, GCWB204, in treating cancer cachexia, and published it in the International Journal of Environmental Research and Public Health.Professor Bae Gyu-un of Sookmyung Women’s University College of Medicine and GC Wellbeing research t
The Ministry of Food and Drug Safety said Monday that Chong Kun Dang has applied for conditional approval of its pancreatitis drug, Nafabeltan (ingredient: nafamostat mesylate), to expand the indication to treating Covid-19.If Chong Kun Dang's drug candidate obtains a regulatory nod, it will become
Roche said its rheumatoid arthritis drug Actemra (ingredient: tocilizumab) obtained the FDA’s nod as the first biologic therapy for treating patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). In Korea, JW Pharmaceutical sells Roche’s Actemra.license gives Roche’s Actemr
Prestige Biopharma said Monday it would build a vaccine production center for Covid-19 and other infectious diseases.The antibody-drug developer said it would break grounds for the vaccine center with the floor space of about 8,500 square meters separate from its second plant for antibody-drug produ
Local drug companies, whose corporate values soared on Covid-19-related R&D plans and new business strategies last year, recently reported disappointing results.On Thursday, Il-yang Pharm said in a public filing that its chronic myeloid leukemia treatment Supect (ingredient: radonitib) failed to dem
Korean biopharmaceutical companies are going all out to win the heart of shareholders, offering bonus issues and cash dividends, according to industry watchers. For instance, Macrogen said Thursday that it had decided to pay 300 won per share in cash dividend. It was such a move since the company’s
Alteogen said Friday it has completed phase 1 clinical trial of ALT-L9, a biosimilar of Regeneron’s Eylea that treats macular degeneration, for the first time in Korea. The company has also finished the registration of formulation patents in the U.S. and Europe and applied for production patent unde
Novartis Korea said that the Ministry of Food and Drug Safety has approved its CAR-T treatment Kymriah (ingredient: tisagenlecleucel) to fight rare blood cancers, ushering in a new approach to cancer treatment.Kymriah is the first customized cell treatment that uses a patient's T-cells to fight canc
Daewoong Pharmaceutical said Friday it has launched a sustained-release, rebamipide-based gastritis treatment, Mucotra SR Tab 150mg.The drug improves gastric mucosal lesions, including inflammation, bleeding, flare and bloating. The company’s previous rebamipide drug should be taken three times a da
Eli Lilly’s tirzepatide, an investigational antidiabetic drug, proved superior to Novo Nordisk’s Ozempic (ingredient: semaglutide) to lower blood sugar and body weight. With the latest data, tirzepatide has become the strongest rival against Ozempic.On Thursday, Lilly announced the outcome of the ph
GC Pharma made official its domestic distribution of Covid-19 vaccines developed by Moderna on Thursday.“We will import and distribute 40 million doses of Moderna's Covid-19 vaccine in Korea,” GC Pharma said. The company added that it would also win the regulatory approval process for the Moderna va
Il-Yang Pharmaceutical said Thursday that its chronic myelogenous leukemia (CML) drug, Supect (Radotinib), has failed to show efficacy in treating Covid-19, in phase 3 clinical trial conducted by a Russian partner R-Pharm.R-Pharm decided not to proceed to receive marketing approval for Supect as Cov
Genexine said it has entered the phase 2a clinical trials of its Covid-19 vaccine candidate GX-19N under development and completed administering the drug to the first group of subjects on Feb. 26.Genexine’s GX-19N is the first homegrown vaccine to enter phase 2 study among products being developed b
GC said Wednesday it has started the shipment of Hunterase ICV (intracerebroventricular), its treatment of hunter syndrome using a ventricular injection.GC became the first company in the world to receive a license to treat severe hunter syndrome in Japan last month.The company expects that the sale
Yuyu Pharmaceutical and the University of California, Los Angeles (UCLA) will develop multiple sclerosis treatment through industry-academic cooperation, Yuyu said on Wednesday.Yuyu and UCLA plan to evaluate the efficacy and safety of candidate materials for the new treatment. Researchers at UCLA ha
Hyundai Pharm made it official that it will supply Mifegyne, an abortive drug, in Korea. Industry watchers said the supply could open ways for medication abortion.However, as the company is preparing for the regulator’s preliminary review before seeking the nod, it will take a considerable time unti
Sanofi and GSK said they would conduct a new phase-2 trial of a Covid-19 vaccine candidate with a better antigen formulation.The two companies recently announced that they would begin a phase-2 study of their adjuvanted recombinant protein Covid-19 vaccine candidate.The study aims to find the optima
Gilead Sciences made headlines worldwide when it developed the world’s first Covid-19 treatment remdesivir last year.The Korean offshoot of the U.S. biopharmaceutical company recorded more than 250 billion won ($222.5 million) revenue despite the small number of staff at around 70. The company showe
Boryung Biopharma said Wednesday it has released a new hepatitis A vaccine, developed by conducting clinical trials on Koreans for the first time.The health authorities included hepatitis type A vaccination into the national inoculation program in 2015 but have supplied only three imported products
As MSD Korea decides to raise the price of Gardasil and Gardasil 9, vaccines for preventing cervical cancer, and RotaTeq, a vaccine for preventing gastroenteritis caused by rotavirus, confusion at local inoculating institutions seems inevitable.MSD Korea recently decided to increase the supply price